U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (STI-6129)Cat. No. WA1684Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (STI-6129)Cat. No. WA1684
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (SG301)Cat. No. WA1683
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (SAR442085)Cat. No. WA1682
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (OKT10-B10)Cat. No. WA1681
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (M267)Cat. No. WA1680
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (GEN3014)Cat. No. WA1679
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (CYT-338)Cat. No. WA1678
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (CM313)Cat. No. WA1677
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (CID-103)Cat. No. WA1676
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 & CD3E Bispecific Antibody (GBR-1342)Cat. No. WA1675
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 & CD3E Bispecific Antibody (AMG-424)Cat. No. WA1674
U-Blot® Research Grade Anti-Human CD38 & BCMA & CD3 Antibody (ISB2001)Cat. No. WA1673